World CB&CDx 2026

Boston, MA
October 5, 2026 – October 7, 2026

Discovery Life Sciences is proud to participate in the 16th World CB&CDx Summit, the leading forum dedicated to companion diagnostics and precision medicine. We look forward to connecting with industry leaders to discuss the evolving companion diagnostics landscape and how Discovery Life Sciences is helping biopharmaceutical partners advance biomarker-driven drug development.

Featured Presentation: 

Thursday, October 8, 2026 | 11:00 AM

Beating the Clock: Why Early Phase CTA Strategy Now Decides the Companion Diagnostics Race

T. Scott Reid, VP and Global Head of Companion Diagnostics, Discovery Life Sciences

  • Oncology drug approval timelines are accelerating, making contemporaneous development of a companion diagnostic through traditional pathways more challenging.
  • Our focus will be accelerating early-phase development and deployment of novel clinical trial assays, with early access to solutions that enable fast decision-making and clinical trial startup.
  • Integrating digital pathology and AI solutions into IHC assay development to get more bang for your biomarker buck.

Schedule a Meeting at World CB&CDx 2026

Quick Links
Privacy Settings